# Hemodynamic Profile of Terlipressin and Octreotide in Patients With Cirrhosis and Portal Hypertension. A Randomised, Single Blinded Clinical Trial.

> **NCT04353193** · PHASE4 · UNKNOWN · sponsor: **Juan A. Arnaiz** · enrollment: 36 (estimated)

## Conditions studied

- Liver Cirrhosis Portal

## Interventions

- **DRUG:** Terlipressin
- **DRUG:** Terlipressin
- **DRUG:** Octreotide

## Key facts

- **NCT ID:** NCT04353193
- **Lead sponsor:** Juan A. Arnaiz
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-06
- **Primary completion:** 2022-02
- **Final completion:** 2022-05
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2020-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04353193

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04353193, "Hemodynamic Profile of Terlipressin and Octreotide in Patients With Cirrhosis and Portal Hypertension. A Randomised, Single Blinded Clinical Trial.". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04353193. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*